- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Kilitch Drugs has approved a 1:1 bonus share issue, meaning one new share for every share held, subject to shareholder approval. The record date for eligibility will be announced soon. This move will double the paid-up equity capital from ₹17.48 Cr to ₹34.96 Cr. This is aimed at enhancing liquidity and market participation, funded by capitalizing existing reserves. #BonusShares #KilitchDrugs #InvestorUpdate